pillbase.ru

Vizimpro

Active substance: dacomitinib

dacomitinib monohydrate

Centralised EU authorisationActive

Marketing holder: Pfizer Europe MA EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • Vizimpro
    TABLET, FILM COATED · DACOMITINIB 45 mg/1
    0069-2299
    Pfizer Laboratories Div Pfizer Inc
  • Vizimpro
    TABLET, FILM COATED · DACOMITINIB 30 mg/1
    0069-1198
    Pfizer Laboratories Div Pfizer Inc
  • Vizimpro
    TABLET, FILM COATED · DACOMITINIB 15 mg/1
    0069-0197
    Pfizer Laboratories Div Pfizer Inc
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-f332-7404-aef2-6a7ab3d35930,01a12091-505e-7322-bf17-d45f8522bf0b,01a1209a-328f-7b72-97aa-f0a1d0d8a2fe;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004779
Registration status
Active
ATC code
L01EB07
Sources
  • product · EMA · EMEA/H/C/004779 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004779 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004779 · Verified 2026-10-09